New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...

Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Bowen, A. and Nargundkar, S. (2025) Transformational Strategies to Improve the Clinical Trial and Drug Development Process.

With a new law that makes it easier for people to access experimental treatments, Montana could become the hub for the ...

Although osteoarthritis is receiving more attention in both the research and clinical arenas than ever, all that attention ...

Novocure NVCR recently announced positive top-line results from its pivotal Phase 3 PANOVA-3 trial, evaluating Tumor Treating ...

Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo's CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 ...

By Sammy CRABBEInfrastructure alone does not make a city great. Roads, grids, and buildings create the skeleton, but it is innovation, creativity, and collaboration that breathe life into the body. As ...

BDC-4182 Phase 1 dose-escalation study now open for enrollmentBDC-3042 Phase 1 dose-escalation data presented at AACR 2025 demonstrated a favorable safety profile, dose-dependent biological activity ...